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Background: The European Society of Cardiology recently proposed a new algorithm “How to diagnose heart failure
with normal ejection fraction”. Central element of the diagnostic strategy is the demonstration of diastolic dysfunction,
either by tissue Doppler-derived indices in first line, or in second line by a combination of elevated blood levels of
natriuretic peptide with abnormal tissue Doppler findings. We thought to use this diagnostic flowchart in a population-
based cohort of elderly women, in whom the prevalence of diastolic dysfunction and heart failure is believed to be
high. The purpose was to evaluate the association of dyspnea with the presence of diastolic dysfunction.
Methods: The study cohort recruited from a cross-sectional follow-up examination of the SALIA cohort (study on the
influence of air pollution on lung function, inflammation, and aging). Participants with cardiac or pulmonary disease
were excluded, 291 participants formed the final study group (all women, age range 69 to 79 years, all in sinus rhythm,
LV ejection fraction > 50%, LV enddiastolic volume index < 97 mL/m
2). Quality of life was assessed by the Minnesota
living with heart failure questionnaire, and actual symptoms by a structural questionnaire; the examination consisted of
a physical examination, measurement of B-type natriuretic peptide, ECG and tissue Doppler echocardiography. Diastolic
dysfunction was assumed when the E/E’ ratio exceeded 15 as derived from tissue Doppler. In case, tissue Doppler
yielded an E/E’ ratio ranging from 8 to 15, additional non-invasive parameters had to be fulfilled: left atrial volume index
>4 0m l / m
2 body surface, or left ventricular mass index > 122 g/m
2 body surface, or transmitral E/A ratio < 0.5 plus
deceleration time > 280 ms, or blood level of brain natriuretic peptide (BNP) > 200 pg/mL.
Results: The examinations were concordant with the presence of diastolic dysfunction in 122/291 participants
(41.9%). The diagnosis based in 94% of cases on two criteria: in 50 cases on the criterion “E/E’ ratio > 15”, and in 65
cases on the criterion “15 > E/E’>8 and LV mass index > 122 g/m
2“. The participants with diastolic dysfunction had
on average a higher body mass index, more frequent a history of arterial hypertension and of hospitalization for
congestive heart failure, poorer quality of life, and higher BNP blood levels as compared to those participants
without signs of diastolic dysfunction. The number of participants complaining exertional dyspnea, however, was
similar distributed among the subgroups with and without signs of diastolic dysfunction (40.2 vs 40.8%; p = n.s). In
a logistic regression model, the symptom dyspnea was best predicted by systolic pulmonary artery pressure,
followed by left atrial volume index, BNP, and body mass index.
Conclusion: The demonstration of diastolic dysfunction showed only a poor association with the symptom dyspnea in
a cohort of elderly women with otherwise normal systolic function. Additional structural or hemodynamic changes are
necessary to “explain” the symptom dyspnea. It is unclear whether these additional factors are secondary to a more
advanced stage of diastolic dysfunction, or are related to cardiovascular co-morbidities, or both.
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In the last two decades, there is growing evidence of pre-
valence and prognosis of heart failure with normal ejec-
tion fraction (HFNEF), also referred to as diastolic heart
failure [1]. HFNEF is characterized by symptoms of heart
failure, signs of elevated ventricular filling pressures and
impaired relaxation in presence of normal systolic func-
tion [2]. In 2007, the Heart Failure and Echocardiography
Associations of the European Society of Cardiology pro-
posed in a consensus statement a diagnostic flowchart
providing a strategy on “How to diagnose HFNEF” [3].
The diagnostic strategy is intended for patients suspected
of having HFNEF and is based on the positive predictive
value of successive examinations. According to this con-
sensus statement, the diagnosis of HFNEF requires a.)
symptoms or signs of heart failure, b.) normal or mildly
abnormal systolic LV function, and c.) evidence of diasto-
lic dysfunction.
Diagnostic evidence of diastolic dysfunction can be
obtained invasively, or - which is probably more accepted
in clinical routine - non-invasively by tissue Doppler. A
central parameter derived from tissue Doppler is the
ratio E/E’ (early diastolic peak filling velocity as derived
from transmitral Doppler/early diastolic peak velocity of
the mitral annulus as derived from tissue Doppler).
When this ratio exceeds 15, the LV filling pressures are
elevated, and - in the presence of normal systolic LV
function - highly suggestive for the presence of diastolic
dysfunction [4,5]. A “grey zone” is the E/E’ ratio ranging
f r o m8t o1 5s u g g e s t i v eb u tn o n d i a g n o s t i cf o rt h ep r e -
sence of diastolic dysfunction. In this case, the consensus
statement suggests implementing additional non-invasive
investigations, such as left atrial volume measurement,
left ventricular mass measurements, combined assess-
ment of transmitral E/A ratio and deceleration time, or
the implementation of blood levels of B-type natriuretic
peptides [3].
We thought to use this diagnostic flowchart in a popu-
lation-based cohort of elderly women, in whom the pre-
valence of diastolic dysfunction and heart failure is
believed to be high [6,7]. The purpose was to evaluate the




The SALIA cohort (Study on the influence of Air popula-
tion on Lung function, inflammation and Aging) was
initiated as part of the Environmental Health Surveys
introduced by the North Rhine Westfalia government
between 1985 and 1994. The study population comprised
4874 women aged 55 at the time of entering the study
who were living in predefined residential areas. The study
areas were chosen from the highly industrialized Ruhr
region which represents a range of high-polluted areas and
two rural counties in the north-west of the Ruhr region as
reference areas [8,9]. In a follow-up of SALIA cohort from
April 2007 to November 2008, 708 women from the Ruhr
region cities Duisburg, Dortmund, Essen and Gelsen-
kirchen and the rural county Borken who survived and
agreed in 2006 to participate in a follow-up were invited
in a randomised manner and, at least 402 women partici-
pated. The protocol of the study was approved by the
Medical Ethic Committee of the Ruhr University Bochum.
All participants gave informed written consent.
Cardiovascular study cohort
A cross-sectional cardiovascular examination was realized
in 344 of 402 participants (86%). The examination con-
sisted of medical history, physical examination, measure-
ment of B-type natriuretic peptide, electrocardiography,
and echocardiography.
Exclusion criteria for further analysis were a.) previous
heart surgery and/or PCI (n = 5), b.) severe heart valve dis-
ease (n = 6), c.) typical angina pectoris ≥ II CCS (n = 3), d.)
previous or actual atrial fibrillation or flutter (n = 8), e.)
permanent pacemaker stimulation (n = 3), and f.) poor
image quality in the echocardiographic examination (n =
10). Nine participants were excluded with a LV EF ≤ 50%
and/or LVEDVI ≥ 97 mL/m
2; further 9 participants were
excluded with pulmonary diseases requiring a specific
therapy. These latter exclusion criteria were chosen to
focus on participants with a normal left ventricular systolic
function and normal left ventricular enddiastolic diameter,
and to exclude those participants with a significant pul-
monary disease. Thus, a total of 291 participants formed
the final study group.
Medical history, quality of life and physical examination
In a structured interview each participant was asked for
detailed medical history, particularly for cardiovascular risk
factors, cardiovascular diseases and medication. The Min-
nesota living with heart failure questionnaire (MLHFQ)
was used to assess quality of life [10]. Summation of the
responses yielded the total MLHFQ score for each patient.
The test ranges between 0 and 110, whereas higher score
indicates a poorer quality of life.
Dyspnea was assessed by combining results of the stan-
dardized questionnaire and an interview. Participants
were asked to asses their degree of functional impairment
due to dyspnea and level of activity. With this, dyspnea
was categorized according to the New York Heart Asso-
ciation classification.
Physical examination comprised measurements of
blood pressure, height, and weight. Arterial hypertension
was diagnosed by medical history, medication and blood
pressure measurement (systolic pressure > 140 mmHg
and/or diastolic blood pressure > 90 mmHg).
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electrocardiography
Plasma B-type (brain) natriuretic peptide levels (BNP)
were measured at the same day as electrocardiography
and echocardiography. The blood samples were collected
in EDTA-containing tubes. After prompt centrifugation,
BNP was measured using a chemiluminescent immunoas-
say kit (Biosite Triage, San Diego, CA, USA). Electrocar-
diography was analyzed for arrhythmias.
Echocardiography
Transthoracic echocardiography was performed according
to the guidelines of the American Society of Echocardio-
graphy [11] using a digital ultrasound scanner (Vivid 7,
General Electrics, Horton, Norway). Data from three car-
diac cycles were analyzed. An experienced cardiologist,
blinded to the participant’s clinical data, performed the
ultrasound examination and interpreted the results. Left
ventricular diameter, posterior wall and septal thickness,
aortic root and left atrial diameter were measured by M-
Mode from the parasternal views. Left atrial volume was
measured by manual tracing of end-systolic endocardial
borders using the apical 4-chamber view. Left ventricular
myocardial mass was calculated according to the Devereux
formula. The Quinones formula was used for measure-
ment of the left ventricular ejection fraction. Values were
averaged for each patient. Right atrial and ventricular
dimensions were measured in apical 4-chamber and para-
sternal short-axis views, tricuspid annular plane systolic
excursion (TAPSE) was measured by M-mode recordings
from the apical 4-chamber view with the cursor placed at
the free wall of the tricuspid valve [12]. Peak velocities of
early (E) and late (A) diastolic filling and deceleration time
were derived from transmitral Doppler profile [2]. Doppler
tissue imaging was taken from medial mitral annulus and
analyzed for early (E’) and late (A’) diastolic peak velocities
[4]. Mitral E/E’ ratio was subsequently calculated.
Inter- and intraobserver correlation for echocardio-
graphic measurements variables reached in our laboratory
0.92 and 0.96, respectively. For assessment of pulmonary
artery pressure (PA sys), the systolic pressure gradient
between right atrium and ventricle was obtained from the
tricuspid regurgitant jet envelope; and the value of
5 mmHg for right atrial pressure was added [13].
Diagnosis of Diastolic Dysfunction
According to the diagnostic flowchart [3], diastolic dys-
function was assumed when the E/E’ ratio exceeded 15 as
derived from tissue Doppler. In case, tissue Doppler
yielded an E/E’ ratio ranging from 8 to 15, additional non-
invasive parameters had to be fulfilled: left atrial volume
index > 40 ml/m
2 body surface, or left ventricular mass
index > 122 g/m
2 body surface, or transmitral E/A ratio <
0.5 plus deceleration time > 280 ms, or blood level of
brain natriuretic peptide > 200 pg/mL.
Statistics
Continuous variables were compared between groups
using an unpaired t test (for normally distributed vari-
ables) or Mann-Whitney U test (for non-normally distrib-
uted variables). Chi-square analysis was used to compare
categorical variables. All reported probability values were
2-tailed, and p < 0.05 was considered statistically signifi-
cant. Stepwise logistic regression analysis was used to esti-
mate the impact (odds ratio, 95% confidence interval) of
the variables history of hypertension, systolic and diastolic
blood pressure, heart rate, body mass index (BMI), BNP,
the echocardiographic parameters E/E’ ratio, left atrial
volume index (LAVI), left ventricular endsystolic/enddias-
tolic volume indices (LVESVI/LVEDVI), left ventricular
mass index (LVMI), right atrial diameter, systolic pulmon-
ary pressure, and TAPSE on the dependent variable dys-
pnea (SPSS Inc., version 18).
Results
The final study group with 291 participants was homoge-
nous regarding sex (all female), age (range 69 to 79
years), heart rhythm (all in sinus rhythm), and left ventri-
cular systolic function and size (LV EF > 50%, LVEDVI <
97 mL/m
2 body surface).
According to the diagnostic flowchart “How to diagnose
HFNEF”, parameters derived from tissue Doppler and
laboratory findings (BNP levels) were concordant with the
presence of diastolic dysfunction in 122 participants
(41.9%). The diagnosis of diastolic dysfunction based in
the majority of cases only on two criteria: in about 17% of
cases (50/291) on the criterion “E/E’ ratio > 15”,a n di n
about 22% of cases (65/291) on the criterion “15 > E/E’>8
and LVMI > 122 g/m
2“ (Figure 1).
The participants with diastolic dysfunction had on aver-
age a higher body mass index (28.34 ± 4.50 vs. 27.01 ±
4.55 kg/m
2; p = 0.014), more frequent a history of arterial
hypertension (82 vs. 63.9%; p = 0.001) and of hospitaliza-
tion for congestive heart failure (13.1 vs. 5.3%; p = 0.033),
poorer quality of life (9.77 ± 10.52 vs 6.84 ± 8.11 score;
p = 0.008), and higher BNP blood levels (86.18 ± 178.92
vs. 51.79 ± 50.4 pg/mL; p = 0.018) as compared to those
participants without signs of diastolic dysfunction. The
number of participants complaining exertional dyspnea,
however, was similar distributed among the subgroups
with and without signs of diastolic dysfunction (40.2 vs
40.8%; p = n.s) (Table 1).
Participants with diastolic dysfunction complained about
dyspnea in 49 cases (40.2%). It was hypothesized that the
participants with dyspnea suffer from a more advanced
stage of diastolic dysfunction, i.e. the parameters used to
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compared to cases without dyspnea. Table 2 compares the
“severity” for diastolic dysfunction in both subgroups with
(n = 49) and without dyspnea (n = 73). The “diagnostic
key parameters” derived from Doppler echocardiography/
tissue Doppler (E/A ratio, DT, E/E’ ratio) revealed on aver-
age no significant differences; however the groups differ





50(17.2%) 2(0.7%) 2(0.7%) 65(22.3%) 3(1.0%)
DiastolicDysfunction(n=122;41.9%)
Figure 1 Definitons for diastolic dysfunction.
Table 1 Comparison of participants with and without diastolic dysfunction
No Diastolic Dysfunction Diastolic dysfunction
Parameter n = 169 n = 122 p
Age, years 74.07 ± 2.53 74.46 ± 2.72 0.210
Body mass index, kg/m
2 27.01 ± 4.55 28.34 ± 4.50 0.014
Hypertension, n (%) 108 (63.9) 100 (82.0) 0.001
Diabetes mellitus, n (%) 15 (8.9) 12 (9.8) 0.941
Current smoking, n (%) 8 (4.7) 1 (1.2) 0.119
Dyslipidemia, n (%) 85 (50.3) 70 (57.4) 0.282
Myocardial infarction, n (%) 8 (4.7) 11 (9.0) 0.145
Hospitalization for CHF, n (%) 9 (5.3) 16 (13.1) 0.033
Stroke, n (%) 4 (2.4) 6 (4.9) 0.394
MLHFQ (score) 6.84 ± 8.11 9.77 ± 10.52 0.008
Dyspnea, n (%) 69 (40.8) 49 (40.2) 0.994
BNP, pg/mL 51.79 ± 50.4 86.18 ± 178.91 0.018
LVEF, % 68.6 ± 6.8 68.1 ± 6.0 0.516
Values are mean ± SD if not otherwise noted; CHF = congestive heart failure, MLHFQ = Minnnesota living with heart failure questionnaire, BNP = brain natriuretic
peptide, LVEF = left ventricular ejection fraction
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parameters which predict best dyspnea in participants
with diastolic dysfunction. The parameters age, LV ejec-
tion fraction and LV volume indices were not added to
this analysis, because these parameters were used as pre-
selection criteria. The parameters history of hypertension,
systolic and diastolic blood pressure, heart rate, the echo-
cardiographic parameters E/E’ ratio and TAPSE did not
show a significant association with the variable dyspnea
(data not shown). Dyspnea was predicted best by the sys-
tolic pulmonary artery pressure, followed by left atrial
volume index, BNP, body mass index, and the parameters
right atrial diameter and LV mass index (Table 3).
Discussion
Diastolic heart failure is characterized by impaired left
ventricular relaxation, increased left ventricular stiffness,
increased interstitial deposition of collagen, and modified
extracellular matrix proteins [1,3]. It has been estimated
that approximately 50% of the heart failure population has
a normal left ventricular ejection fraction, and diastolic
heart failure may be - at least partially - responsible for
heart failure signs and symptoms [1]. Compared with
patients with heart failure and reduced LV ejection frac-
tion, individuals with HFNEF are typically older, more
likely women, and have a higher likelihood of arterial
hypertension [14]. The prognosis of patients with HFNEF
appears to be only hardly better than that of individuals
with heart failure and impaired LV systolic function
[15,16]. While life expectancy increasing, HFNEF may be a
growing health problem.
A prerequisite in the diagnosis of HFNEF is the evi-
dence of diastolic dysfunction. The reported prevalence
of LV diastolic dysfunction in the general population var-
ies from 11.1 to 34.7% [6,17-20], and may depend on var-
ious factors, in particular the characteristics of the
population studied, and the criteria applied to define dia-
stolic dysfunction. In the present cohort of preselected
elderly (age range 69-79 years) women with a normal LV
ejection fraction and a normal LV geometry, the rate of
diastolic dysfunction was as high as 42%. In agreement to
previous studies [6,19,20] diastolic dysfunction was asso-
ciated with a higher body mass index, more frequent
with a history of arterial hypertension, a poorer quality of
life and higher BNP blood levels as compared to those
participants without signs of diastolic dysfunction.
A key element in the diagnosis of HFNEF is the evi-
dence of elevated LV filling. Three ways have been pro-
posed to diagnose raised LV filling pressures: a. invasive
measurements, b. unequivocal tissue Doppler measure-
ments, and c. a combination of Doppler echocardio-
graphic parameters and elevated BNP blood levels [3].
Conventional Doppler echocardiographic indices (E/A
ratio derived from mitral inflow and pulmonary venous
flow patterns) have clear limitations and rarely allow the
accurate differentiation between normal from pseudonor-
mal mitral inflow pattern [1]. In the present study we
used for diagnosing diastolic dysfunction the flowchart as
proposed by the Heart Failure and Echocardiography
Associations of the ESC [3]. We focused on the non-inva-
sive arm of the flowchart because of practicability in a
population-based survey. This non-invasive arm of the
flowchart emphasizes the E/E’ ratio derived from tissue
Doppler as one key element of diagnosis of diastolic dys-
function with an E/E’ ratio > 15 being unequivocal for
elevated LV filling pressures. In the present study popula-
tion, about 17% of cases alone fulfilled this criterion (41%
of total subgroup with evidence of diastolic dysfunction).
An E/E’ ratio between 8 and 15 appears suggestive but
nondiagnostic for diastolic dysfunction, and the flowchart
demands further measurements. In the present study we
used some but not all criteria proposed by the flowchart:
we ignored the criterion “presence of atrial fibrillation”,
because sinus rhythm was an inclusion criterion, as well
as the criterion “difference between duration of reverse
pulmonary vein atrial systole flow and duration of mitral
Table 3 Logistic regression analysis, dependent variable
dyspnea
Parameter Odds Ratio P 95% Confidence Interval
PA sys 1.249 .000 1.113 - 1.400
LAVI 1.098 .001 1.037 - 1.162
BNP 1.011 .001 1.004 - 1.109
BMI 1.151 .002 1.053 - 1.257
Septal thickness 1.404 .009 1.089 - 1.811
RAD 1.126 .014 1.025 - 1.238
LVESDI 1.074 .026 1.009 - 1.145
LVMI 1.018 .027 1.002 - 1.033
PAsys = systolic pulmonary artery pressure; RAD = right atrial diameter; BMI =
body mass index; LVESDI = left ventricular endsystolic diameter index; for
other abbreviations see tables 1&2; for parameters LAVI, BMI, septal thickness,
RAD, LVESDI and LVMI were measurements available in 122 participants;
measurements were available for PAsys and BNP in 50 and 99 participants,
respectively
Table 2 Presence of diastolic dysfunction - comparison of
participants with and without dyspnea
No Dyspnea Dyspnea
Parameter n = 73 n = 49 p
BNP, pg/mL 57.1 ± 63.1 164.2 ± 266.6 0.023
LAVI, ml/kg
2 21.7 ± 6.4 26.8 ± 9.1 0.001
LVMI, g/kg
2 132.2 ± 26.0 141.7 ± 27.8 0.048
E/A ratio 0.85 ± 0.31 0.95 ± 0.44 0.139
DT, sec 245.7 ± 58.3 239.0 ± 65.7 0.556
E/E’ ratio 14.2 ± 3.7 15.3 ± 6.1 0.237
Values are mean ± SD; LAVI = left atrial volume index; LVMI = left ventricular
mass index; E = early diastolic filling peak velocity; A = late diastolic filling
peak velocity; DT = deceleration time; E/E’ ratio = ratio early diastolic filling
velocity/mitral annular peak velocity
Germing et al. BMC Geriatrics 2011, 11:71
http://www.biomedcentral.com/1471-2318/11/71
Page 5 of 7valve atrial flow > 30 ms”, because the pulmonary vein
flow pattern was not routinely assessed in our study
population. The combined criterion “15>E/E’>8 and left
ventricular mass index > 122 g/m
2 (for women)” was
positive in our study cohort in 22.3% of cases (53% of
total subgroup with evidence of diastolic dysfunction).
Taken together, the diagnosis of diastolic dysfunction
based in our study population in 94% of cases on two cri-
teria only.
The flowchart allows an alternative pathway to diag-
nose diastolic dysfunction: the use of the biomarkers
brain natriuretic peptide (BNP) or NT-proBNP in first
line, in combination with an E/E’ ratio > 8. In our study
population, 7.6% of participants fulfilled this criterion
(data not shown). This number is in sharp contrast to
the above mentioned cases with diastolic dysfunction
diagnosed by tissue Doppler indices in first line (42%).
Somewhat unexpected, the diagnosis of diastolic dys-
function (using tissue Doppler in first line for diagnosis)
showed only a poor association with the symptom
“dyspnea”. In fact, approximately 40% of elderly women in
the present study cohort complained dyspnea: this symp-
tom, however, was similar distributed among the sub-
groups with and without signs of diastolic dysfunction.
The “key parameters” for the diagnosis of diastolic dys-
function (E/A ratio and deceleration time; E/E’ ratio) did
not further discriminate those women with diastolic dys-
function and dyspnea. Additional echocardiographic para-
meters such as the systolic pulmonary pressure, left atrial
volume index, right atrial diameter, and left ventricular
mass index were more helpful to characterize participants
with dyspnea. This observation suggests that the demon-
stration of elevated LV filling pattern by tissue Doppler
alone may be not sufficient to “explain” the symptom dys-
pnea in elderly patients, and other factors have to be taken
into consideration. Several causes of dyspnea in elderly
have been described [21]. Shortness of breath may be asso-
ciated with older age, poor perceived health, anxiety and
depressive symptoms, impaired daily functioning, lower
happiness or muscular disabilities. Our data does not
allow discriminating between two possibilities: a. the addi-
tional factors may be related to a more advanced stage of
diastolic dysfunction with secondary structural and hemo-
dynamic changes, b. the additional factors are the result of
co-morbidities such as left ventricular hypertrophy or pul-
monary arterial hypertension. Since the magnitude of the
E/E’ ratio did not correlate with the symptom dyspnea in
women classified for diastolic dysfunction, our data favors
the latter suggestion.
A sal i m i t i n gf a c t o rw eh a v et oc o n s i d e r ,t h a tw ec a n
not thoroughly generalize our data to the community
because of the study exclusion criteria. However, we
wanted to analyze the interplay between diastolic func-
tion and dyspnea without apparent underlying diseases.
Conclusion
In summary, our population-based cross-sectional study in
elder women confirms a high percentage of participants
with signs of diastolic dysfunction, as assessed by the
actual diagnostic guidelines of the ESC. According to the
guidelines, the diagnosis of diastolic dysfunction based in
the majority of cases on two criteria (E/E’ ratio > 15,
15>E/E’>8 and LVMI > 122 g/m
2). The demonstration of
diastolic dysfunction showed only a poor association with
the symptom dyspnea. Additional structural or hemody-
namic changes are necessary to “explain” the symptom
dyspnea in this cohort of elderly women. It is unclear
whether these additional factors are secondary to a more
advanced stage of diastolic dysfunction, or are related to
cardiovascular co-morbidities, or both.
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